Profil Financier
Karin Sartorius-Herbst occupe actuellement le rang #1660 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.5 B (+$195 sur 24h).
Karin Sartorius-Herbst inherited a stake in Sartorius AG, which makes pharmaceutical an laboratory equipment.
Her great-grandfather Florenz Sartorius founded what become Sartorius AG in 1870 to make analytical balances to measure small mass in laboratories.
Her father, Horst Sartorius, died in 1998 and left a 50% stake to his daughters Karin, Christine Franken and Ulrike Baro.
An executor oversees their inheritance until 2028.
Today, the company has more than 15,000 employees and annual revenue exceeding $5 billion. It went public in 1990.
Sartorius-Herbst has had roles in various voluntary endeavors and charitable entities throughout her life.
She studied economics at the University of Goettingen.